Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
USPH

USPH - US Physical Therapy Inc Stock Price, Fair Value and News

94.47USD-0.23 (-0.24%)Market Closed

Market Summary

USPH
USD94.47-0.23
Market Closed
-0.24%

USPH Alerts

  • 4 major insider sales recently.

USPH Stock Price

View Fullscreen

USPH RSI Chart

USPH Valuation

Market Cap

1.4B

Price/Earnings (Trailing)

49.3

Price/Sales (Trailing)

2.33

EV/EBITDA

17.25

Price/Free Cashflow

18.97

USPH Price/Sales (Trailing)

USPH Profitability

EBT Margin

8.13%

Return on Equity

6.02%

Return on Assets

2.84%

Free Cashflow Yield

5.27%

USPH Fundamentals

USPH Revenue

Revenue (TTM)

612.0M

Rev. Growth (Yr)

4.83%

Rev. Growth (Qtr)

0.56%

USPH Earnings

Earnings (TTM)

28.9M

Earnings Growth (Yr)

8.58%

Earnings Growth (Qtr)

1.1K%

Breaking Down USPH Revenue

Last 7 days

-2.5%

Last 30 days

-12.5%

Last 90 days

-11.5%

Trailing 12 Months

-14.9%

How does USPH drawdown profile look like?

USPH Financial Health

Current Ratio

2.16

USPH Investor Care

Dividend Yield

1.83%

Dividend/Share (TTM)

1.73

Shares Dilution (1Y)

15.35%

Diluted EPS (TTM)

1.17

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024612.0M000
2023569.9M580.8M591.2M604.8M
2022514.4M528.1M541.8M553.1M
2021422.6M465.7M482.7M495.0M
2020478.5M435.9M427.6M423.0M
2019461.8M473.1M477.2M482.0M
2018424.8M435.7M445.8M453.9M
2017367.2M381.0M395.7M414.1M
2016341.0M348.1M352.4M356.5M
2015312.5M317.6M324.0M331.3M
2014271.1M282.4M294.3M305.1M
2013250.6M254.1M257.8M264.1M
2012242.0M245.5M247.9M249.7M
2011217.6M223.4M229.7M237.0M
20100204.7M208.0M211.2M
2009000201.4M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of US Physical Therapy Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
May 30, 2024
reading christopher j
sold
-290,754
100
-2,900
chairman of the board and ceo
May 29, 2024
reading christopher j
sold
-100,130
100
-1,000
chairman of the board and ceo
May 28, 2024
reading christopher j
sold
-112,343
102
-1,100
chairman of the board and ceo
May 20, 2024
gilmartin kathleen a
acquired
-
-
1,424
-
May 20, 2024
motsenbocker anne
acquired
-
-
1,424
-
May 20, 2024
harris bernard a jr
acquired
-
-
1,424
-
May 20, 2024
ham nancy
acquired
-
-
1,424
-
May 20, 2024
trier clayton
acquired
-
-
1,424
-
May 20, 2024
hendrickson carey p
gifted
-
-
-201
chief financial officer
May 20, 2024
swanson regg e.
acquired
-
-
1,424
-

1–10 of 50

Which funds bought or sold USPH recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 30, 2024
EULAV Asset Management
unchanged
-
1,534,990
8,781,290
0.24%
May 28, 2024
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
unchanged
-
79,000
447,000
-%
May 24, 2024
Cetera Investment Advisers
new
-
518,299
518,299
-%
May 24, 2024
Northwest Bank & Trust Co
unchanged
-
3,348
40,604
0.04%
May 21, 2024
Atria Investments, Inc
reduced
-4.68
179,558
1,336,320
0.02%
May 16, 2024
COMERICA BANK
reduced
-6.68
117,376
1,013,520
-%
May 16, 2024
JANE STREET GROUP, LLC
reduced
-49.66
-253,933
397,302
-%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-5.17
219,421
1,690,570
-%
May 15, 2024
Alpine Peaks Capital, LP
reduced
-7.36
1,056,270
9,665,850
5.57%
May 15, 2024
CRAWFORD INVESTMENT COUNSEL INC
added
2.54
2,032,180
10,409,100
0.19%

1–10 of 48

Are Funds Buying or Selling USPH?

Are funds buying USPH calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own USPH
No. of Funds

Unveiling US Physical Therapy Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
t. rowe price investment management, inc.
5.1%
761,260
SC 13G
Feb 13, 2024
morgan stanley
6.9%
1,039,417
SC 13G/A
Feb 13, 2024
vanguard group inc
7.09%
1,062,427
SC 13G/A
Feb 13, 2024
kayne anderson rudnick investment management llc
9.11%
1,365,766
SC 13G/A
Jan 22, 2024
blackrock inc.
15.5%
2,318,096
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
0.2%
29,108
SC 13G/A
Feb 14, 2023
t. rowe price investment management, inc.
7.0%
915,831
SC 13G
Feb 14, 2023
kayne anderson rudnick investment management llc
11.78%
1,531,533
SC 13G/A
Feb 10, 2023
morgan stanley
5.1%
656,785
SC 13G
Feb 09, 2023
vanguard group inc
7.10%
922,576
SC 13G/A

Recent SEC filings of US Physical Therapy Inc

View All Filings
Date Filed Form Type Document
Jun 05, 2024
8-K
Current Report
May 31, 2024
4
Insider Trading
May 31, 2024
8-K
Current Report
May 30, 2024
8-K
Current Report
May 29, 2024
4
Insider Trading
May 28, 2024
144
Notice of Insider Sale Intent
May 21, 2024
4
Insider Trading
May 21, 2024
8-K
Current Report
May 21, 2024
4
Insider Trading
May 21, 2024
4
Insider Trading

Peers (Alternatives to US Physical Therapy Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
457.5B
379.5B
-3.96% 6.69%
29.78
1.21
12.96% -25.81%
94.7B
206.0B
-2.91% 23.68%
24.57
0.46
12.55% -43.95%
88.3B
66.7B
3.14% 17.96%
16.15
1.32
9.59% -4.59%
75.6B
360.9B
7.06% -13.34%
10.32
0.21
9.07% 78.83%
36.8B
155.5B
-11.76% 4.22%
13.45
0.24
6.34% 84.42%
12.6B
14.7B
3.05% 27.06%
15.46
0.86
7.99% 19.23%
12.4B
12.3B
2.37% 45.10%
15.18
1
5.77% 58.74%
MID-CAP
8.1B
2.3B
-5.14% -0.84%
28.75
3.55
5.96% 18.29%
6.1B
3.0B
-4.96% -11.02%
-536.83
2.03
10.92% -104.06%
2.2B
1.5B
-3.99% 23.33%
35.44
1.52
19.34% 40.15%
2.1B
3.5B
-8.09% -48.91%
14.6
0.6
-27.67% -62.40%
SMALL-CAP
1.9B
1.1B
4.89% 26.11%
28.99
1.75
11.45% 30.74%
1.3B
3.0B
-6.18% 62.93%
-7.41
0.42
4.98% 4.88%
61.1M
-
7.91% -14.07%
-4.04
-
- -1.05%
20.0M
21.6M
-7.87% 21.54%
39.38
0.93
9.04% -57.88%

US Physical Therapy Inc News

Latest updates
Yahoo Singapore News34 hours ago

US Physical Therapy Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue0.6%15615515015114914114014113213012612711211710984.00113122117126116
Gross Profit-6.9%28.0031.0028.0032.0031.0028.0027.0031.0027.0027.0030.0034.0026.0029.0030.0019.0016.0027.0027.0031.0027.00
Costs and Expenses2.4%12712412211911811311311010510396.0093.0086.0088.0079.0065.0097.0095.0090.0095.0090.00
  S&GA Expenses1.3%14.0014.0012.0012.0014.0012.0012.0011.0012.0011.0013.0012.0011.0011.0010.009.0012.0012.0011.0012.0011.00
EBITDA Margin0.3%0.12*0.12*0.13*0.13*0.13*0.14*0.16*0.16*0.17*0.17*0.19*0.20*---------
Interest Expenses10.9%2.002.003.003.001.004.001.001.001.000.000.000.000.00-0.001.000.000.001.001.000.00
Income Taxes124.4%3.001.004.004.003.001.003.004.003.004.004.005.003.005.004.004.000.002.003.005.003.00
Earnings Before Taxes13820.8%15.000.0016.0019.0014.005.0016.0019.0015.0018.0018.0022.0015.0023.0020.0019.004.0014.0016.0025.0015.00
EBT Margin-0.5%0.08*0.08*0.09*0.09*0.10*0.10*0.13*0.14*0.14*0.15*0.16*0.17*---------
Net Income1126.5%8.001.009.0011.007.003.0010.0011.009.0010.0010.0012.008.0013.0011.0010.001.008.009.0015.008.00
Net Income Margin1.1%0.05*0.05*0.05*0.05*0.05*0.06*0.07*0.08*0.08*0.08*0.09*0.10*---------
Free Cashflow-83.5%4.0027.0016.0027.0011.0017.0014.0016.0012.0016.0025.0018.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets2.0%1,0179971,0101,000868858800796764749630749749594575585594631561561523
  Current Assets-5.2%22123322824211811111312296.0095.0079.0080.0076.0088.0083.0092.0014985.0093.0010781.00
    Cash Equivalents-13.4%13215314816133.0032.0038.0049.0024.0029.0019.0020.0018.0033.0030.0044.0090.0024.0028.0035.0020.00
  Net PPE0.6%26.0026.0026.0025.0025.0025.0025.0024.0024.0023.0022.0022.0022.0022.0021.0023.0023.0022.0021.0020.0021.00
  Goodwill4.8%534510523507501494450443444435374374360346337331331318317304293
Liabilities0.1%345345342344384374333336304297201195182184170192260181188193165
  Current Liabilities0.3%10310282.0086.0091.0085.0081.0085.0089.0083.0082.0075.0091.0093.0093.0087.0071.0061.0063.0057.0069.00
    LT Debt, Current19.9%9.008.008.008.008.008.007.005.001.001.001.001.005.005.005.005.001.001.001.001.001.00
Shareholder's Equity0.8%480476492490319317319309302297291285277278266257242242237231221
  Retained Earnings-0.1%224224239238235233236232227224219216210212203195183184181177169
  Additional Paid-In Capital0.9%28428127927711211010910710510310299.0097.0096.0093.0091.0090.0087.0086.0084.0082.00
Accumulated Depreciation2.3%87.0085.0085.0084.0082.0080.0079.0077.0077.0075.0074.0072.0070.0069.0068.0067.0067.0066.0065.0064.0065.00
Shares Outstanding5.8%15.0014.0014.0014.0013.0013.0013.0013.0013.0013.0013.0013.00---------
Minority Interest20.2%1.001.002.002.001.001.001.002.001.002.001.001.001.001.001.001.001.001.002.001.001.00
Float----1,100---774---838---565---779-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-83.5%4,41926,83516,36427,43011,34917,29913,72715,86211,64915,90524,94517,88217,67425,39326,24631,97616,38015,98417,84315,05813,563
  Share Based Compensation11.9%1,9971,7851,8591,7861,8061,8021,8021,8141,8461,5872,8751,7541,6512,5921,9361,5031,8861,7231,7041,8301,728
Cashflow From Investing-143.2%-20,464-8,414-16,941-6,979-12,681-43,391-14,338-7,596-15,944-79,878-10,883-20,172-13,203-28,288-4,836-2,156-15,923-6,028-6,724-20,611-4,630
Cashflow From Financing66.2%-4,490-13,281-12,476107,6822,34319,772-10,04716,077-43.0073,352-15,2934,772-19,4525,684-34,836-75,81665,546-14,264-18,12220,174-12,063
  Dividend Payments-100.0%-6,4456,445--5,3315,33110,659-4,8314,9069,028-----3,8323,832--
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

USPH Income Statement

2024-03-31
UNAUDITED CONSOLIDATED STATEMENTS OF NET INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues:  
Net revenue$ 155,675$ 148,509
Operating cost:  
Salaries and related costs93,73186,040
Rent, supplies, contract labor and other31,91630,100
Provision for credit losses1,6271,512
Total operating cost127,274117,652
Gross profit28,40130,857
Corporate office costs14,08513,859
Operating income14,31616,998
Other income (expense):  
Interest expense, debt and other(1,968)(2,560)
Interest income from investments1,54364
Change in fair value of contingent earn-out consideration612(698)
Change in revaluation of put-right liability(80)(149)
Equity in earnings of unconsolidated affiliate271274
Relief Funds0467
Other620
Total other income (expense)440(2,602)
Income before taxes14,75614,396
Provision for income taxes3,1392,969
Net income11,61711,427
Less: Net income attributable to non-controlling interest:  
Redeemable non-controlling interest - temporary equity(2,227)(2,720)
Non-controlling interest - permanent equity(1,344)(1,297)
Net income attributable to non-controlling interest(3,571)(4,017)
Net income attributable to USPH shareholders$ 8,046$ 7,410
Basic earnings per share attributable to USPH shareholders (in dollars per share)$ 0.46$ 0.58
Diluted earnings per share attributable to USPH shareholders (in dollars per share)$ 0.46$ 0.58
Shares used in computation - basic (in shares)15,01713,025
Shares used in computation - diluted (in shares)15,01713,025
Dividends declared per common share (in dollars per share)$ 0.44$ 0.43
Net Patient Revenue [Member]  
Revenues:  
Net revenue$ 131,075$ 126,581
Other Revenue [Member]  
Revenues:  
Net revenue$ 24,600$ 21,928

USPH Balance Sheet

2024-03-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 132,290$ 152,825
Patient accounts receivable, less provision for credit losses of $2,936 and $2,736, respectively55,36351,866
Accounts receivable - other21,77417,854
Other current assets11,71510,830
Total current assets221,142233,375
Fixed assets:  
Furniture and equipment65,55063,982
Leasehold improvements47,45846,941
Fixed assets, gross113,008110,923
Less accumulated depreciation and amortization(86,757)(84,821)
Fixed assets, net26,25126,102
Operating lease right-of-use assets102,113103,431
Investment in unconsolidated affiliate12,16012,256
Goodwill534,271509,571
Other identifiable intangible assets, net116,888109,682
Other assets4,4312,821
Total assets1,017,256997,238
Current liabilities:  
Accounts payable - trade4,8663,898
Accrued expenses53,74955,344
Current portion of operating lease liabilities34,69935,252
Current portion of term loan and notes payable9,2227,691
Total current liabilities102,536102,185
Notes payable, net of current portion8041,289
Term loan, net of current portion and deferred financing costs135,945137,702
Deferred taxes27,33724,815
Operating lease liabilities, net of current portion75,68076,653
Other long-term liabilities2,9882,356
Total liabilities345,290345,000
Redeemable non-controlling interest - temporary equity190,733174,828
Commitments and Contingencies
U.S. Physical Therapy, Inc. ("USPH") shareholders' equity:  
Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding00
Common stock, $.01 par value, 20,000,000 shares authorized, 17,282,822 and 17,202,291 shares issued, respectively172172
Additional paid-in capital283,546281,096
Accumulated other comprehensive gain4,1082,782
Retained earnings223,573223,772
Treasury stock at cost, 2,214,737 shares(31,628)(31,628)
Total USPH shareholders' equity479,771476,194
Non-controlling interest - permanent equity1,4621,216
Total USPH shareholders' equity and non-controlling interest - permanent equity481,233477,410
Total liabilities, redeemable non-controlling interest, USPH shareholders' equity and non-controlling interest - permanent equity$ 1,017,256$ 997,238
USPH
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. The company was founded in 1990 and is based in Houston, Texas.
 CEO
 WEBSITEusph.com
 INDUSTRYHealthcare Plans
 EMPLOYEES3570

US Physical Therapy Inc Frequently Asked Questions


What is the ticker symbol for US Physical Therapy Inc? What does USPH stand for in stocks?

USPH is the stock ticker symbol of US Physical Therapy Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of US Physical Therapy Inc (USPH)?

As of Fri Jun 14 2024, market cap of US Physical Therapy Inc is 1.42 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of USPH stock?

You can check USPH's fair value in chart for subscribers.

What is the fair value of USPH stock?

You can check USPH's fair value in chart for subscribers. The fair value of US Physical Therapy Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of US Physical Therapy Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for USPH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is US Physical Therapy Inc a good stock to buy?

The fair value guage provides a quick view whether USPH is over valued or under valued. Whether US Physical Therapy Inc is cheap or expensive depends on the assumptions which impact US Physical Therapy Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for USPH.

What is US Physical Therapy Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jun 14 2024, USPH's PE ratio (Price to Earnings) is 49.3 and Price to Sales (PS) ratio is 2.33. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. USPH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on US Physical Therapy Inc's stock?

In the past 10 years, US Physical Therapy Inc has provided 0.121 (multiply by 100 for percentage) rate of return.